{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:16:00Z","timestamp":1787015760430,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"Supplement_S1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The purpose of this report was to provide consensus recommendations for the use of immunosuppressive therapy in dogs with active glomerular diseases. Recommendations were developed based on comprehensive review of relevant literature on immunosuppressive therapy of glomerular disease in dogs and humans, contemporary expert opinion, and anecdotal experience in dogs with glomerular disease treated with immunosuppression. Recommendations were subsequently validated by a formal consensus methodology. The Study Group recommends empirical application of immunosuppressive therapy for dogs with severe, persistent, or progressive glomerular disease in which there is evidence of an active immune-mediated pathogenesis on kidney biopsy and no identified contraindication to immunosuppressive therapy. The most compelling evidence supporting active immune-mediated mechanisms includes electron-dense deposits identified with transmission electron microscopic examination and unequivocal immunofluorescent staining in the glomeruli. For diseases associated with profound proteinuria, attendant hypoalbuminemia, nephrotic syndrome, or rapidly progressive azotemia, single drug or combination therapy consisting of rapidly acting immunosuppressive drugs is recommended. The Study Group recommends mycophenolate alone or in combination with prednisolone. To minimize the adverse effects, glucocorticoids should not be used as a sole treatment, and when used concurrently with mycophenolate, glucocorticoids should be tapered as quickly as possible. For stable or slowly progressive glomerular diseases, the Study Group recommends mycophenolate or chlorambucil alone or in combination with azathioprine on alternating days. Therapeutic effectiveness should be assessed serially by changes in proteinuria, renal function, and serum albumin concentration. In the absence of overt adverse effects, at least 8 weeks of the rapidly acting nonsteroidal drug therapy and 8\u201312 weeks of slowly acting drug therapy should be provided before altering or abandoning an immunosuppressive trial.<\/jats:p>","DOI":"10.1111\/jvim.12228","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T20:15:55Z","timestamp":1385410555000},"page":"S44-S54","source":"Crossref","is-referenced-by-count":25,"title":["Consensus Recommendations for Immunosuppressive Treatment of Dogs with Glomerular Disease Based on Established Pathology"],"prefix":"10.1093","volume":"27","author":[{"name":"IRIS Canine GN Study Group Established Pathology Subgroup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Segev","sequence":"additional","affiliation":[{"name":"Koret School of Veterinary Medicine (Segev), The Hebrew University of Jerusalem , Rehovot,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.D.","family":"Cowgill","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California-Davis Department of Medicine and Epidemiology (Cowgill), , Davis, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Heiene","sequence":"additional","affiliation":[{"name":"Blue Star Animal Hospital, Gothenburg, Sweden and PetVett Dyresykehus , Oslo,","place":["Norway (Heiene)"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Labato","sequence":"additional","affiliation":[{"name":"Foster Hospital for Small Animals, Cummings School of Veterinary Medicine, Tufts University Department of Clinical Sciences (Labato), , North Grafton, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Polzin","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Minnesota Department of Veterinary Clinical Sciences (Polzin), , St Paul, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"2026021205521609100_jvim12228-bib-0001","first-page":"2021","volume-title":"Textbook of Veterinary Internal Medicine","author":"Vaden","year":"2010"},{"key":"2026021205521609100_jvim12228-bib-0002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5326\/15473317-32-4-313","article-title":"Clinical and pathological features of protein-losing glomerular disease in the dog: A review of 137 cases (1985-1992)","volume":"32","author":"Cook","year":"1996","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026021205521609100_jvim12228-bib-0003","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00335-002-2253-9","article-title":"Genetic cause of X-linked Alport syndrome in a family of domestic dogs","volume":"14","author":"Cox","year":"2003","journal-title":"Mamm Genome"},{"key":"2026021205521609100_jvim12228-bib-0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cvsm.2010.09.006","article-title":"Protein-losing nephropathy in small animals","volume":"41","author":"Littman","year":"2011","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026021205521609100_jvim12228-bib-0005","first-page":"987","volume-title":"The Kidney","author":"Nachman","year":"2007","edition":"8th ed"},{"key":"2026021205521609100_jvim12228-bib-0006","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1517\/14656566.2010.494599","article-title":"Management of idiopathic membranous nephropathy","volume":"11","author":"Ponticelli","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"2026021205521609100_jvim12228-bib-0007","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2143(98)90146-9","article-title":"Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency","volume":"131","author":"Brown","year":"1998","journal-title":"J Lab Clin Med"},{"key":"2026021205521609100_jvim12228-bib-0008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2460\/javma.1987.190.01.81","article-title":"Clinicopathologic, renal immunofluorescent, and light microscopic features of glomerulonephritis in the dog: 41 cases (1975-1985)","volume":"190","author":"Center","year":"1987","journal-title":"J Am Vet Med Assoc"},{"key":"2026021205521609100_jvim12228-bib-0009","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"2026021205521609100_jvim12228-bib-0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2005.08.003","article-title":"Pulse steroids: How much is enough?","volume":"5","author":"Franchin","year":"2006","journal-title":"Autoimmun Rev"},{"key":"2026021205521609100_jvim12228-bib-0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1748-5827.2011.01024.x","article-title":"Immunomodulatory drugs and their application to the management of canine immune-mediated disease","volume":"52","author":"Whitley","year":"2011","journal-title":"J Small Anim Pract"},{"issue":"Suppl 1","key":"2026021205521609100_jvim12228-bib-0012","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"2026021205521609100_jvim12228-bib-0013","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2007.00136.x","article-title":"Mycophenolate mofetil","volume":"20","author":"Zwerner","year":"2007","journal-title":"Dermatol Ther"},{"key":"2026021205521609100_jvim12228-bib-0014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1476-4431.2010.00606.x","article-title":"Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats","volume":"21","author":"Bacek","year":"2011","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026021205521609100_jvim12228-bib-0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2460\/javma.236.6.664","article-title":"Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008)","volume":"236","author":"Dewey","year":"2012","journal-title":"J Am Vet Med Assoc"},{"key":"2026021205521609100_jvim12228-bib-0016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1751-0813.2007.00201.x","article-title":"Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetil","volume":"85","author":"Yuki","year":"2007","journal-title":"Aust Vet J"},{"key":"2026021205521609100_jvim12228-bib-0017","article-title":"Evaluation of combined treatment with mycophenolate mofenil and prednisone for dogs with meningoencephalitis of unknown etiology: Retrospective case series of 25 dogs","volume-title":"European Society of Veterinary Neurology","author":"Barnoon"},{"key":"2026021205521609100_jvim12228-bib-0018","first-page":"132","article-title":"An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases","volume":"5","author":"Appel","year":"2009","journal-title":"Nat Clin Pract Nephrol"},{"key":"2026021205521609100_jvim12228-bib-0019","first-page":"103","article-title":"The use of mycophenolate mofetil in the treatment of a case of immune-mediated glomerulonephritis in a dog","volume":"31","author":"Banyard","year":"2001","journal-title":"Aust Vet Pract"},{"key":"2026021205521609100_jvim12228-bib-0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1939-1676.1995.tb01077.x","article-title":"The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis","volume":"9","author":"Vaden","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026021205521609100_jvim12228-bib-0021","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2460\/javma.1977.171.03.259","article-title":"Cyclophosphamide-induced cystitis in the dog and cat","volume":"171","author":"Crow","year":"1977","journal-title":"J Am Vet Med Assoc"},{"key":"2026021205521609100_jvim12228-bib-0022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.autrev.2012.11.012","article-title":"Standard immunosuppresive therapy of immune-mediated glomerular diseases","volume":"12","author":"Pani","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2026021205521609100_jvim12228-bib-0023","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2460\/javma.1988.192.09.1316","article-title":"Azathioprine for treatment of immune-mediated diseases of dogs and cats","volume":"192","author":"Beale","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"2026021205521609100_jvim12228-bib-0024","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1939-1676.1992.tb00340.x","article-title":"Immunosuppressive therapy in the treatment of immune-mediated disease","volume":"6","author":"Miller","year":"1992","journal-title":"J Vet Intern Med"},{"key":"2026021205521609100_jvim12228-bib-0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1746-6148-7-15","article-title":"Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: A retrospective cohort study","volume":"7","author":"Piek","year":"2011","journal-title":"BMC Vet Res"},{"key":"2026021205521609100_jvim12228-bib-0026","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2460\/javma.1987.191.06.695","article-title":"Acute pancreatitis in two dogs given azathioprine and prednisone","volume":"191","author":"Moriello","year":"1987","journal-title":"J Am Vet Med Assoc"},{"key":"2026021205521609100_jvim12228-bib-0027","first-page":"612","article-title":"Azathioprine-induced bone marrow toxicity in four dogs","volume":"37","author":"Rinkardt","year":"1996","journal-title":"Can Vet J"},{"key":"2026021205521609100_jvim12228-bib-0028","first-page":"496","article-title":"Acute pancreatitis and bone marrow suppression in a dog given azathioprine","volume":"32","author":"Houston","year":"1991","journal-title":"Can Vet J"},{"key":"2026021205521609100_jvim12228-bib-0029","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026021205521609100_jvim12228-bib-0030","first-page":"425","article-title":"Day-to-Day variation of the urine protein: Creatinine ratio in female dogs with stable glomerular proteinuria caused by X-linked hereditary nephropathy","volume":"21","author":"Nabity","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026021205521609100_jvim12228-bib-0031","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1939-1676.2007.tb03005.x","article-title":"Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"21","author":"Brown","year":"2007","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12228","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/27\/Supplement_S1\/S44\/66684456\/jvim12228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/27\/Supplement_S1\/S44\/66684456\/jvim12228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:52:25Z","timestamp":1770893545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/27\/Supplement_S1\/S44\/8451844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":31,"journal-issue":{"issue":"Supplement_S1","published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12228","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,11]]},"published":{"date-parts":[[2013,11,1]]}}}